3.2.6 Emerging reviews and mechanistic syntheses point toward cardiorenal, musculoskeletal, and multisystem expansion, but many proposed indications remain exploratory Recent reviews consistently describe a therapeutic expansion beyond diabetes and obesity into cardiovascular disease, renal protection, NAFLD, neurodegenerative disease, inflammation, hypertension, arthritis, and other conditions (Nauck et al., 2021), (Zheng et al., 2024), (Drucker, 2025)
Frequently Asked Questions Are GLP-1 medications approved for treating anxiety
Sleep quality can be affected by both the autoimmune condition and, at higher doses, by GLP-1 therapy itself
Experimental models have demonstrated that phenytoin and carbamazepine activate the nuclear receptors PXR and constitutive androstane receptor (CAR), inducing CYP3A4-mediated VD hydroxylation and CYP24A1 overexpression through genomic and post-translational mechanisms [152]
Acute cholecystitis (gallbladder infection) and biliary colic are the most common presentations